Inherited variations in the SOD and GPX gene families and cancer risk

Arseniy E Yuzhalin1, Anton G Kutikhin

  • 1Department of Genetics, Kemerovo State University, Kemerovo, Russian Federation. yuzhalin@gmail.com

Free Radical Research
|January 20, 2012
PubMed

Insights

Antioxidant enzymes like superoxide dismutase (SOD) and glutathione peroxidase (GPX) combat oxidative stress. Specific gene variants (polymorphisms) in these enzymes may increase cancer risk, potentially serving as future biomarkers.

Area of Science:

  • Biochemistry and Molecular Biology
  • Genetics and Genomics
  • Cancer Research

Background:

  • Oxidative stress, caused by reactive oxygen species (ROS), damages cellular components including DNA.
  • ROS can lead to genomic instability and aberrant cell processes, increasing cancer risk.
  • Antioxidant defence enzymes, such as superoxide dismutase (SOD) and glutathione peroxidase (GPX), mitigate oxidative damage.

Purpose of the Study:

  • To review the impact of common single nucleotide polymorphisms (SNPs) in SOD and GPX gene families on carcinogenesis.
  • To explore the potential of these genetic variations as cancer risk biomarkers.

Main Methods:

  • Literature review focusing on single nucleotide polymorphisms (SNPs) within the superoxide dismutase (SOD) and glutathione peroxidase (GPX) gene families.
  • Analysis of the association between specific genetic variants and cancer development.
  • Evaluation of the predictive significance of identified polymorphisms.

Main Results:

  • Certain single nucleotide polymorphisms (SNPs) in SOD and GPX genes significantly alter enzyme function.
  • Specific alleles of these antioxidant genes are associated with increased risk for particular cancer types.
  • The predictive significance of several polymorphisms in relation to cancer predisposition was determined.

Conclusions:

  • Genetic variations in antioxidant defence genes like SOD and GPX play a role in cancer development.
  • Identified risk alleles may serve as valuable genomic markers for cancer predisposition.
  • Further in-depth research into these polymorphisms is recommended for early cancer prevention strategies.

Related Concept Videos

Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
Pleiotropy01:33

Pleiotropy

Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters01:16

Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters

The pharmacogenetics of drug transporters is increasingly recognized as a critical factor influencing interindividual variability in drug absorption, distribution, and elimination. These membrane-bound proteins regulate drugs' movement across cellular barriers by actively pumping them out (efflux) or facilitating their uptake (influx). Among the major transporter families, ATP-binding cassette (ABC) and solute carrier (SLC) transporters play particularly prominent roles. Genetic polymorphisms...
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...